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In vitro differences between smooth muscle cells
derived from varicose veins and normal veins
Ying Xiao, PhD,a Zhibin Huang, MD,b Henghui Yin, PhD,a Ying Lin, PhD,a and
Shenming Wang, PhD,a Guangzhou, Peoples Republic of China
Objective: The theory of primary venous dilatation leading to secondary valvular incompetence and varicose vein
formation has received more attention nowadays. Although many studies have investigated the role of the main
components of the venous wall in the development of varicose veins, the leading cause remains unknown. The present
study was designed to establish the role of smooth muscle cells (SMCs) of the tunica media on the pathogenesis of
varicose veins by analyzing the phenotypic and functional differences between SMCs derived from varicose veins and
normal veins.
Methods: SMCs were isolated and cultured from saphenous veins of patients with varicose veins and normal veins. Cell
proliferation andmigration rates were compared. Expression of phenotype-dependent markers andmatrix metalloproteinase-
2 (MMP) production were analyzed by immunoblotting. Total collagen synthesis was evaluated by measuring the
radioactivity of L-[3, 4-3H]proline in the media and the cell layer.
Results: SMCs derived from varicose veins demonstrated increased proliferation (2-fold, P< .01), migration (3-fold, P<
.001), MMP-2 production (3-fold, P < .01), and collagen synthesis (>2-fold, P < .001), with decreased expression of
phenotype-dependent markers compared with SMCs derived from normal veins (P < .05).
Conclusion: SMCs derived from varicose veins are more dedifferentiated and demonstrate increased proliferative and
synthetic capacity than SMCs derived from normal veins. These properties may contribute to the remodeling of the
venous wall and the weakening of its antipressure capacity. ( J Vasc Surg 2009;50:1149-54.)
Clinical Relevance: Primary varicose veins are one of the most common diseases of periphery veins. We provide evidence
that the alteration of biologic behaviors in cultured smooth muscle cells derived from varicose veins may contribute to the
development of varicose veins. Therefore, medications that can help to maintain a nonmobile state of smooth muscle cells
will prevent the progress of the disease.Primary varicose veins are a frequent and refractory
disease of the peripheral veins. The elusive nature of vari-
cose vein formation and its wide prevalence throughout the
world make it necessary to understand the mechanisms
involved in the pathogenesis of the disease.
It has been well recognized that both primary incom-
petent valves and primary venous wall weakness can lead to
the formation of varicose veins. However, the theory of
primary venous wall dilation resulting from venous wall
weakness has received more attention nowadays.1 What is
the cause of venous wall weakness? A lot of research on the
components of the venous wall, including collagen and
elastic content and smooth muscle cells (SMCs) of the
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the answer remains unclear.
Vascular SMCs (VSMCs) are mature cells that maintain
great plasticity. Previous studies on the pathology of vari-
cose veins have shown that SMCs phenotypically appear
transformed from a contractile to a synthetic state.5-11
These studies, however, draw their conclusions through
only one aspect of SMC behavior or histologic examina-
tion. The present study attempted to make a detailed in
vitro comparison of SMC behavior, including proliferation,
migration, collagen synthesis, matrix metalloproteinase 2
(MMP-2) production and the phenotypic dependent
markers, to identify differences in phenotype and function
between SMCs derived from normal veins and those de-
rived from varicose veins. The aim of this work was to verify
that differences do exist in the biologic behaviors of SMCs
derived from normal veins and varicose veins. These differ-
ences may contribute to venous wall remodeling and weak-
ness.
MATERIALS AND METHODS
Specimens. SMCs were isolated from two groups of
human saphenous veins. Thirteen control veins were ob-
tained from patients (7 men, 6 women; 58.7  1.2 years
(range, 52-68 years) undergoing coronary artery bypass
grafting. Patients had no history or symptoms of varicose
veins and no retrograde flow proven by duplex ultrasound
(DU) examinations. Twelve varicose veins were obtained
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years; range, 50-69 years) who were undergoing saphenec-
tomy by stripping. All patients were diagnosed with pri-
mary varicose veins, with reflux confirmed by DU studies.
By the CEAP classification, these patients were all type 2
(C2). The study was approved by the local ethics commit-
tee, and informed consent was obtained from each patient.
Cell cultures. Explants from the medial layer of two
groups of saphenous veins were prepared as previously
described.5 Cells were grown in 25 flasks in Dulbecco
modified Eagle medium (DMEM,Hyclone) supplemented
with 10% fetal bovine serum (FBS, Hyclone), L-glutamine
(2 mmol/L), penicillin (105 U/L), streptomycin (100
g/mL), and nonessential amino acids (100 g/mL) at
37°C in a 95% air and 5% carbon dioxide atmosphere. The
culture medium was changed every 3 days. Cell growth
began within 7 to 14 days, and cells reached confluence
after 4 weeks.
Cells were trypsinized, seeded at a density of 10,000/
cm2 (first passage) in culture flasks without precoating, and
subcultured. Only cells from passages 0 to 2 were used.
Before each experiment, the phenotypes of the SMCs were
confirmed by immunofluorescence with a monoclonal an-
tibody against human -actin (clone ASM-1; Chemicon).
All experiments were repeated a minimum of three times
from SMCs of at least three different patients.
Assessment of cell proliferation. [3H]-thymidine in-
corporation and cell counting were used in the assessment
of cell proliferation as previously described.12 Briefly, 1 
104 cells/well were seeded onto 24-well plates with com-
plete media and allowed to adhere for 24 hours. The
medium was replaced by serum-free medium for 48 hours
to achieve synchronous growth arrest. Then 10% FBS was
added as a stimulator of proliferation. At 48 hours after
stimulation, [3H]-thymidine (1 mCi/mL; specific activity,
20 Ci/mmol) was added to the cells and they were incu-
bated 24 hours.
The cells were then washed, fixed with 10% trichloro-
acetic acid (TCA), and lysed with 0.3M NaOH and 1%
sodium dodecyl sulfate (SDS) solution. Reactivity was
counted in a Beckman scintillation counter. For cell count-
ing, 5  103 cells/well were seeded in 96-well plates and
the cells were trypsinized. Viable cells were counted using a
hemocytometer for a period of 8 days. The experiments
were done in triplicate.
Scratch wound migration assay. Cell migration was
measured by using a monolayer scratch injury assay, as
described previously.13 Confluent cultures of SMCs grown
in 6-well plates were wounded with a 200-L pipette tip
and incubated in standard culture medium. After 48 hours
of incubation, the cells that hadmoved into the wound area
were quantified. Four counts were made at various points
along each wound that had been photographed initially and
marked. Migrated cell numbers were derived from the
average of these fields in triplicates.
Western blotting. Protein extracts were obtained by
disrupting the cells in lysis buffer (0.05 mol/L HEPES,
0.15 mol/L NaCl, 1% NP-40, 1 nmol/L MgCl2, 1mmol/L CaCl2). Supernatants containing cytoplasmic
proteins were collected and the protein concentration was
determined by BCA method (Protein Assay Kit; Keygen
Biotec, Nanjing, China). For each sample, 50-g total
protein was subjected to SDS-polyacrylamide gel electro-
phoresis on a 6% to 12% polyacrylamide gel. Separated
proteins were electrophoretically transferred onto poly-
vinylidene fluoride membranes for immunodetection. Af-
ter a blocking step with 5% non-fat milk in 0.02M Tris
(0.05% Tween 20), membranes were incubated with pri-
mary antibodies diluted in blocking buffer, followed by
horseradish peroxidase-conjugated appropriated secondary
antibodies. Antigens were visualized by enhanced chemilu-
minescence. The bands on the film were quantified and
normalized to -actin.
Collagen synthesis assay. Because the major biosyn-
thetic destination of proline is collagen, the incorporation
of amino acid into newly synthesized proteins provides a
reliable index of collagen synthesis. The amounts of radio-
activity incorporated into soluble and insoluble protein
fractions provide an assessment of collagen released into
media (soluble protein) and that which was released but
incorporated in and around the cell layer (insoluble pro-
Fig 1. A, Cell proliferation was significantly higher (days 4 to 8)
in smoothmuscle cells (SMCs) derived from varicose veins. During
days 7 to 8, cell numbers were 1.8-fold that of SMCs derived from
normal veins. B, [3H]-thymidine incorporation in SMCs de-
rived from varicose veins was nearly twofold that of SMCs
derived from normal veins. The error bars show the standard
deviation. *P  .01.tein).14
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containing 50 Gi/mL L-[3,4-3H]proline was added to
each well. After 48 hours, the media were removed from
the cells. TCA was added to the media to give a final
concentration of 10% and left on ice for 1 hour. Precipi-
tated protein was collected by centrifugation at 3000g for
30 minutes, washed with 4 mL ice-cold 10% TCA to
remove any unincorporated labeled proline, and centri-
fuged again. The supernatant was carefully removed and
the pellet suspended in 0.3 mL of 0.3MNaOH/0.3% SDS.
The preparations were then warmed to 37°C until solubi-
lized and added to 4 mL of liquid scintillant.
The cell layer was washed twice with PBS and removed
from the plates by scraping into 1mL of ice-cold 10% TCA.
Precipitated protein was collected by centrifugation at
14,000g for 20 minutes. The cell layer precipitate was
solubilized at 37°C for 1 hour in 0.3 mL of 0.3M NaOH/
0.3% SDS and added to 4 mL of liquid scintillant. Radio-
activity was counted in both the media and cell layer
Fig 2. Representative result of wound healing assay sh
(SMCs) derived from varicose veins. The bar graph show
higher than that of SMCs derived from normal veins. Thsamples on a liquid scintillation analyzer.Statistics. All experiments were performed at least
three times, and values are expressed as mean  standard
deviation. Statistical significance (P .05) was determined
using independent samples t test.
RESULTS
Proliferation of SMC. Cell proliferation was signifi-
cantly higher in varicose veins SMCs during days 4 to 7,
with a cell number nearly 1.7-fold that of the number in
SMCs derived from normal veins at the plateau phase (day
8; Fig 1, A). DNA synthesis was nearly twofold that of the
value in varicose veins SMCs 48 hours after seeding com-
pared with SMCs derived from normal veins (Fig 1, B).
Migration of SMC. Migration of SMCs derived from
varicose veins was threefold that of SMCs derived from
normal veins (Fig 2).
Expression of phenotype-dependent markers of
vascular SMC. The expression level of contractile (differ-
entiation) markers in VSMCs is a useful paradigm in the
a significantly higher migration in smooth muscle cells
ration of SMCs derived from varicose veins was twofold
or bars show the standard deviation. *P  .001.ows
s miganalysis of SMC phenotypic transition.15 Varicose veins
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notype with less -smooth muscle (-SM) actin, smooth
muscle myosin heavy chain (SM-MHC), and smoothelin
expression than SMCs derived from normal veins. Levels of
-SM actin, SM-MHC, and smoothelin were reduced to
about 30%, 20%, 30%, respectively, of the values in cells
derived from normal veins (Fig 3).
Collagen synthesis alteration in VSMC. The incor-
poration of L-[3,4-3H]proline into the cell layer and in the
medium of varicose veins SMCs was significantly higher
than into normal veins SMCs, more than twofold that of
the SMCs derived from normal veins (Fig 4).
MMP-2 production in VSMCs. Previous studies
Fig 3. Expression of smooth muscle cell (SMC) phenotype-
dependent markers in SMCs derived from normal veins and varicose
veins. SMCs of the same passage were used for proteins extraction.
Western blotting analysis of an equal amount of sample proteins
showed decreased expression of -actin, smoothelin, and smooth
muscle myosin heavy chain (SM-MHC) in SMCs derived from
varicose veins, which indicate a dedifferentiated phenotype alter-
ation. Bar graphs indicate the relative ratios of the band intensity of
detected proteins normalized to -actin levels as loading control.
*P  .01. The graphs are representative of three independent
experiments. The results are means  standard deviation (error
bars).have shown that MMP-2 play a pivotal role in the regula-tion and rearrangement of extracellular matrix components
of the venous wall16 and can precipitate varicose vein
formation.17,18 Consistent with a previous report,8 we also
found a significant higher production of MMP-2 in SMCs
derived from varicose veins (Fig 5).
DISCUSSION
Varicose veins are a common vascular disorder of the
lower extremity that affect 10% to 40% of people aged 30 to
70 years.19 This study was designed to evaluate the role of
SMCs in the pathogenesis of varicose veins.
The differentiation state of SMC has been implicated in
various vascular pathologies such as atherosclerosis,20,21
and intimal hyperplasia.22,23 The principal function of ma-
ture SMCs is contraction. These cells have a high cytoplas-
mic volume fraction of myofilaments,24,25 a low rate of
proliferation,26 and synthesize only small amounts of ma-
trix proteins.27
Several studies have described phenotypic alterations of
Fig 4. Collagen synthesis was significantly higher in smoothmus-
cle cells (SMCs) derived from varicose veins both in the (A) cell
layer and in the (B) media. *P  .001 compared with SMCs
derived from normal veins. The error bars indicate the standard
deviation.SMCs in varicose veins.5-11 The electron microscopy find-
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ferentiated, with an increase in secretory cytoplasmic or-
ganelles, which could reflect unusual possible synthetic and
secretory roles of SMCs. The findings also showed a reduc-
tion in filament bundles, which could imply the decreased
contractility of SMCs in varicose veins.6 No available study
has directly testified that there are phenotypic changes in
varicose vein-derived SMCs, and these phenotypic alter-
ations may contribute to the weakness of the venous wall.
In our study, we cultured the SMCs derived from
varicose veins and normal veins and directly compared their
biologic behavior. Our data showed that SMCs derived
from varicose veins have significantly increased capabilities
of proliferation, migration, and synthesis. This result can
explain what we have seen in the hypertrophic portion of
varicose veins, a high degree of cellularity both in the
medial and in the thickened intima, which means SMCs
have migrated to the intima and caused collagenization.
Our study also showed a decreased expression of SMC
phenotype-dependent proteins, including -SM actin, SM-
MHC, and smoothelin. These are consistent with the char-
acteristic of dedifferentiated phenotype of SMCs. Although
we have not evaluated the contractility of SMC directly, the
reduced levels of expression of VSMC contractile proteins
Fig 5. A,RepresentativeWestern blot formatrixmetalloproteinase-
2 (MMP-2) production shows MMP-2 production was signifi-
cantly higher in SMCs derived from varicose veins than in SMCs
derived from normal veins. B, The relative ratios of the band
intensity of detected proteins normalized to -actin are shown
with the standard deviation (error bars). *P  .05.can reflect the decreased contractility of SMCs derived fromvaricose veins. Contractile properties of human saphenous
smooth muscle are essential to maintain the required tone
in vein wall.28,29 Impaired contractility of SMCs with dis-
turbance of extracellular matrix organization5 may contrib-
ute to the primary weakness of venous wall.
Previous studies have investigated cultured SMCs de-
rived from varicose veins to determine that the extracellular
matrix modifications seen in varicose veins tissue are related
to SMCs.5,8 Increased expression of MMPs could induce
degradation of extracellular matrix proteins and thus affect
the mechanical properties of the vein wall. Recent evidence
also suggests an effect of MMP-2 on SMCs of the vein wall,
thereby causing changes in the venous constriction/relax-
ation properties.17
MMP-2 can be produced by SMCs, so it has raised an
interesting question of whether SMCs derived from vari-
cose veins can synthesize more MMP-2 than those from
normal veins. Previous studies have shown that the plasma
and venous tissue levels of MMP-2 are elevated in varicose
veins.8 Consistent with previous reports, our study found
the SMCs derived from varicose veins demonstrated ac-
tive synthetic capacity. They synthesized not only large
amounts of collagen but also collagenase. The increased
level of MMP-2 could induce not only degradation of
collagen content16 and migration of smooth muscle cells30
but also venous relaxation by a mechanism involving hyper-
polarization and activation of BKca,17 which leads to pro-
gressive venous dilatation and formation of varicose veins.
Previous studies indicated that structural, biochemical,
and functional changes in varicose tributaries and in non-
varicose veins from the same patient were similar,31 which
suggested that abnormalities within the vein wall exist
before the varicosities develop and the defect of the vein
wall may be the initial event of the disease. Our study results
indicate that SMCs derived from varicose veins have partic-
ular intrinsic characteristics that may contribute to the
primary defect of the vein wall. This study reinforced the
notion that the imbalance in matrix production and degra-
dation is intimately associated with the phenotype and
function of SMCs. Our findings suggest that a genetic
modification may have occurred in SMCs in patients with
varicose veins.
CONCLUSIONS
Regardless of what caused these changes, our findings
confirm the major role of SMCs, which could be ultimately
responsible for the varicose process occurring in the vein
wall because they are able to control both venous wall tone
and extracellular matrix organization. Furthermore, this in
vitro model can be used to explore the cellular and molec-
ular mechanisms underlying the pathogenesis of varicose
veins and to analyze the pathways involved in the SMCs
phenotypic modulation, which may help develop new ther-
apeutic strategies to prevent the progress of the disease.
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